The novel treatment of tirzepatide peptide represents a exciting development in the care of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide targets two pathways – GLP-1 and GIP – leading to https://tirzepatidepeptide967421.blogdosaga.com/42090986/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment